drugset / Trial / NCT02013323

Clinical and Microbiological Efficacy of Systemic Ayurvedic Immunomodulator Septilin in the Treatment of Chronic Periodontitis

NCT02013323 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The present clinical trial was designed to investigate the clinical and microbiological effectiveness of systemic ayurvedic immunomodulator Septilin as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis (CP)

Timeline

Start
2013-03
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Septilin Traditional medicine (herbal / TCM) 500 mg Oral

Indications